1. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance
   Shabnam Malik et al, 2024, Cancer and Metastasis Reviews CrossRef
2. Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma
   Suchisnigdha Datta et al, 2023, Frontiers in Pharmacology CrossRef
3. Ferroptosis As Ultimate Target of Cancer Therapy
   Yashiro Motooka et al, 2023, Antioxidants & Redox Signaling CrossRef
4. Exosomes from EGFR-Mutated Adenocarcinoma Induce a Hybrid EMT and MMP9-Dependant Tumor Invasion
   Amina Jouida et al, 2022, Cancers CrossRef
5. The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations
   Aditya Kulkarni et al, 2021, Oncotarget CrossRef
6. Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research
   Kamila Wojas-Krawczyk et al, 2020, Frontiers in Oncology CrossRef
7. Underpinning the Cellular and Molecular Mechanisms with Nanotheranostics for Lung Cancer
   Asiya Mahtab et al, 2021, Targeting Cellular Signalling Pathways in Lung Diseases CrossRef
8. Detoxifying effects of optimal hyperoxia (40% oxygenation) exposure on benzo[a]pyrene-induced toxicity in human keratinocytes
   Yong Chan Kwon et al, 2020, Journal of Toxicology and Environmental Health, Part A CrossRef
9. CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis
   Yanbo Wang et al, 2021, Frontiers in Oncology CrossRef
10. Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
    Kexun Zhou et al, 2023, Frontiers in Immunology CrossRef